Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02452268 |
| Title | A Phase I/Ib Study of NIZ985 in Combination With PDR001 in Adults With Metastatic Cancers |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| National Cancer Institute National Cancer Institute | Bethesda | Maryland | 20892 | United States | Details | |
| Washington University School of Medicine SC | Saint Louis | Missouri | 63110 | United States | Details | |
| The Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43212 | United States | Details | |
| Providence Portland Medical Center SC | Portland | Oregon | 97123 | United States | Details | |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | United States | Details | |
| Seattle Cancer Care Alliance | Seattle | Washington | 98105 | United States | Details | |
| University of Wisconsin | Madison | Wisconsin | 53792 | United States | Details |